does bpc 157 cause insomnia The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety BPC given in eye drops

Moreover, the SURPASS programme demonstrated that tirzepatide 15 mg is more efficacious in glycaemic control for people with T2D compared to insulin therapies as well as GLP-1 mono-agonists including semaglutide 1 mg and dulaglutide 1.5 mg

Diabetes can damage nerves directly through years of raised blood sugar, and Diabetes UK explains that this diabetic neuropathy most often shows up in the feet as numbness, tingling or burning pain

It is being explored for obesity and related metabolic conditions, including broader applications in metabolic health research

Invest 133 (17), e169314

administration, TAT-DAT NT , at the dose of 40 nmol ( i.c.v